Literature DB >> 7194433

Progressive supranuclear palsy, computed tomography, and response to antiparkinsonian drugs.

S Haldeman, J W Goldman, J Hyde, H F Pribram.   

Abstract

Three patients with progressive supranuclear palsy demonstrated atrophy of the midbrain, pons, cerebellum, and cerebral hemispheres by computed tomography with horizontal, sagittal, and coronal reconstruction. Benztropine therapy resulted in improvement of speech and gait without significantly affecting the vertical gaze palsy.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7194433     DOI： 10.1212/wnl.31.4.442

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  6 in total

1.  Treatment of progressive supranuclear palsy with methysergide. A clinical study.

Authors:  G Di Trapani; P Stampatore; A La Cara; A Azzoni; M L Vaccario
Journal:  Ital J Neurol Sci       Date:  1991-04

Review 2.  Progressive supranuclear palsy: clinical features, pathophysiology and management.

Authors:  A Rajput; A H Rajput
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Radiology of the ambient cistern. Part II: Pathology.

Authors:  D W Chakeres; A Kapila; D LaMasters
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

4.  Current and future treatments in progressive supranuclear palsy.

Authors:  Irene van Balken; Irene Litvan
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.598

5.  Neurophysiological assessment in progressive supranuclear palsy.

Authors:  R Schoenhuber; P Bortolotti; E Vescovini
Journal:  Ital J Neurol Sci       Date:  1983-09

6.  Computed tomographic findings in progressive supranuclear palsy.

Authors:  H Saitoh; F Yoshii; Y Shinohara
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.